Forward Industries filed an automatic shelf to offer up to $4 billion in at-the-market common stock to support its Solana (SOL) treasury strategy.Forward Industries filed an automatic shelf to offer up to $4 billion in at-the-market common stock to support its Solana (SOL) treasury strategy.

Forward Industries Files $4 Billion ATM Offering to Boost Solana Treasury

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
solanamain1

Forward Industries, Inc., the design firm turned Solana-focused treasury company, today announced an automatic shelf registration and an at-the-market (ATM) equity offering program that could raise up to $4 billion in common stock sales.

Under the newly filed registration (Form S-3, File No. 333-290312), Forward has included an ATM prospectus that covers the potential sale of shares (the “ATM Shares”) through Cantor Fitzgerald & Co., which is acting as sales agent under a Sales Agreement dated September 16, 2025.

Sales made under the program would be conducted as “at the market offerings” under Rule 415(a)(4) of the Securities Act and, according to the agreement, Cantor will use commercially reasonable efforts to sell shares on mutually agreed terms, but is not obliged to sell any specific number or dollar amount.

Accelerating Solana Treasury Strategy

Forward says any net proceeds from the ATM Program, if realized, will be used for general corporate purposes, including working capital; advancing its Solana token (SOL) strategy; buying income-generating assets to grow the business; and other capital expenditures. The company’s move follows its September 2025 decision to pursue a dedicated Solana treasury strategy and its initial purchases of more than 6.8 million SOL.

“Through this offering, Forward Industries gains a flexible and efficient mechanism to raise and methodically deploy capital in support of our Solana treasury strategy,” said Kyle Samani, Chairman of the Board of Directors of Forward Industries. “Having recently completed the largest Solana-focused digital asset treasury raise to date and initial purchases of more than 6.8 million SOL, the ATM Program enhances our ability to continue scaling that position, strengthen our balance sheet, and pursue growth initiatives in alignment with our long-term vision.”

The ATM Shares, if sold, will be offered pursuant to Forward’s automatic shelf registration statement, which the company says became effective upon filing with the U.S. Securities and Exchange Commission on September 17, 2025. The company noted there is no arrangement for funds to be held in escrow, trust or a similar arrangement in connection with the program.

Forward Industries highlighted that its Solana treasury strategy is backed by leading investors and operating partners, including Galaxy Digital, Jump Crypto and Multicoin Capital. The company, a global design firm that has worked with top medical and technology companies for more than 60 years, said the initiative is aimed at increasing SOL-per-share through bespoke strategies and active treasury management.

Market Opportunity
Solana Logo
Solana Price(SOL)
$84.62
$84.62$84.62
-0.02%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09